High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study
Abstract Background For people with opioid use disorder (OUD), extended-release naltrexone (XR-NTX) is an effective antagonist treatment option. However, successful opioid tapering and abstinence is a prerequisite for XR-NTX induction and has repeatedly been reported as a major barrier to effective...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-06-01
|
| Seri Bilgileri: | Addiction Science & Clinical Practice |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13722-025-00576-9 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|